OncoCyte
In Brief This Week: Oncocyte, Lucid Diagnostics, T2 Biosystems, All of Us, Myriad Genetics, More
News items for the week of Nov. 11, 2024
Oncocyte Nets $10.2M in Private Placement, Notes New Customers for Transplant Test
The company intends to use the funds for general corporate purposes as it seeks to gain customers and regulatory support for its GraftAssure transplant rejection test.
Oncocyte Notified That It Lost, Regained Nasdaq Compliance
The issue arose with the death in April of a board member, who was also a member of Oncocyte's audit committee, and was resolved with a new appointment this month.
People in the News at Oncocyte, 10x Genomics
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
Earnings Roundup: DermTech, Exagen, Lucid Diagnostics, Oncocyte
These genomics and molecular diagnostics firms posted their quarterly financial results this week.
Jul 24, 2023
Oncocyte Initiates 1-for-20 Reverse Stock Split
Apr 13, 2023